Structure Therapeutics Inc ADR
Structure Therapeutics Inc ADR (GPCR) Unusual Options Activity Today
GPCR options volume power reached 12.5x on the previous trading day. The highest reading was on the $47.5 CALL expiring 2026-11-20.
Read more
Checking GPCR unusual options activity helps you spot when traders are making outsized bets on Structure Therapeutics Inc ADR before the broader market catches on. Structure Therapeutics Inc ADR's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor GPCR unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching GPCR unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking GPCR unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and GPCR unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF.
The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.
Catalysts rarely arrive without a footprint, and GPCR unusual options activity is often where that footprint shows up first. Our scanner tracks Structure Therapeutics Inc ADR's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at GPCR unusual options volume on the call side or chasing put sweeps, Structure Therapeutics Inc ADR's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 40.00 | 0.80 | 1.20 | 1.00 | 70% | 454 | 570 | 79.65% |
| 42.50 | 0.40 | 0.75 | 0.58 | 71% | 75 | 97 | 77.32% |
| 35.00 | 1.30 | 4.00 | 2.65 | 63% | 133 | 309 | 43.04% |
| 75.00 | — | 0.20 | 0.20 | 160% | 3 | 22 | 13.64% |
| 55.00 | — | 0.15 | 0.15 | 99% | 25 | 281 | 8.90% |
| 60.00 | 21.80 | 26.10 | 23.95 | 85% | 2 | 9 | 22.22% |
| 35.00 | 1.00 | 2.50 | 1.75 | 66% | 11 | 190 | 5.79% |
| 42.50 | 4.90 | 8.60 | 6.75 | 57% | 1 | 20 | 5.00% |
| 20.00 | — | 2.15 | 2.15 | 301% | 0 | 0 | — |
| 22.50 | — | 2.15 | 2.15 | 257% | 0 | 0 | — |
As of September 30, 2026
Spot unusual options activity before it moves
Track GPCR options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→